Skip to content

A comparative study of the therapeutic effects of obstructive sleep apnea syndrome in children under the guidance of etiology classification and conventional regimens

A comparative study of the therapeutic effects of obstructive sleep apnea syndrome in children under the guidance of etiology classification and conventional regimens

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064528
Enrollment
Unknown
Registered
2022-10-11
Start date
2022-10-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSAS

Interventions

Group 1 :
Group 2:
Group 3:

Sponsors

Children's Hospital, Capital Institute of Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age from 3 to 17 years; 2. The patient was diagnosed as OSAHS by PSG examination, meeting the diagnostic criteria of OSAHS in children: OAHI > 1 time/hour.

Exclusion criteria

Exclusion criteria: 1. Previous history of otolaryngology or craniofacial surgery; 2. Have medical or psychological diseases related to hypoxemia, sleep splitting, cognitive/behavioral problems, developmental disorders, and are currently taking drugs that are known to affect sleep, respiratory dynamics, or neuropsychological functions; 3. Contraindications to surgery; 4. Other sleep disorders such as CSAHS; 5. Laryngeal spasm, hypothyroidism, epilepsy, neuromuscular diseases and other diseases; 6. History of cardiopulmonary disease; 7. History of anesthetic allergy; 8. Claustrophobia.

Design outcomes

Primary

MeasureTime frame
Preoperative/postoperative polysomnography;

Secondary

MeasureTime frame
Treatment efficiency among groups;

Countries

China

Contacts

Public ContactGu Qinglong

Children's Hospital, Capital Institute of Pediatrics

gql71@163.com+86 13146836613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026